Fig. 2From: In vitro anticancer activity of folate-modified docetaxel-loaded PLGA nanoparticles against drug-sensitive and multidrug-resistant cancer cellsThe release profile of docetaxel from F–NP–Doc nanoparticles at 37 °C (the initial amount of docetaxel in the sample was taken as 100%)Back to article page
